CN Patent
CN102453024B — 一种尼罗替尼盐酸盐晶型及其制备方法
Assigned to Zhejiang Jiuzhou Pharmaceutical Co Ltd · Expires 2014-09-03 · 12y expired
What this patent protects
本发明提供一种式(I)所示的尼罗替尼盐酸盐的新晶形,所述尼罗替尼盐酸盐晶形使用Cu-Kα辐射,用晶面间距d、布拉格角2θ和相对强度表达的X射线衍射图谱如表1所示。与现有技术相比,本发明提供尼罗替尼盐酸盐新晶形具有更好的溶解度。
USPTO Abstract
本发明提供一种式(I)所示的尼罗替尼盐酸盐的新晶形,所述尼罗替尼盐酸盐晶形使用Cu-Kα辐射,用晶面间距d、布拉格角2θ和相对强度表达的X射线衍射图谱如表1所示。与现有技术相比,本发明提供尼罗替尼盐酸盐新晶形具有更好的溶解度。
Drugs covered by this patent
- nilotinib-hydrochloride (Nilotinib Hydrochloride) · Jan Beumer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.